Systole Remedies, India’s largest Contract Research and Manufacturing Organization (CRAMS) is responsible for producing approximately 11-12 % of all medicines consumed in India. Systole Remedies offers a wide range of services, including formulation development and market launch.

Systole Remedies is a leading provider of integrated solutions for businesses seeking to achieve specific business and development goals. The company also offers advanced solutions in formulation development and testing. Systole Remedies’ total revenue was more than INR 21 billion in 2016-17. This figure is up more than 20% from the previous year.

Our regulatory approvals such as WHO & GMP, which are accredited to our manufacturing facility, reflect our sincerity in ensuring the quality